Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents for Diffuse Long Coronary Artery Disease
Clinical trial NCT02831205 · TERMINATED
Trial details
- NCT number
- NCT02831205
- Sponsor
- Duk-Woo Park, MD
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-12-01
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.